Browsing by Author Sekmek, Serhat

Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
2025Impact of First-Line Tyrosine Kinase Inhibitor Selection on Survival Outcomes With Second-Line Nivolumab in Metastatic Renal Cell CarcinomaKuzu, Omer Faruk; Bolek, Hatice; Camoz, Elif Sertesen; Karakas, Hilal; Sekmek, Serhat; Sim, Saadet; Urun, Yuksel
2025The Impact of Smoking on Nivolumab Outcomes in Renal Cell Carcinoma: Real-World Data From the Turkish Oncology Group Kidney Cancer ConsortiumCamoz, Elif Sertesen; Bolek, Hatice; Kuzu, Omer Faruk; Sim, Saadet; Karakas, Hilal; Sekmek, Serhat; Urun, Yuksel
2025Uric Acid Level in Metastatic Renal Cell Carcinoma Treated With Nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) StudySekmek, Serhat; Bolek, Hatice; Kuzu, Omer Faruk; Camoz, Elif Sertesen; Sim, Saadet; Karakas, Hilal; Urun, Yuksel